Head and neck cancer: Altered fractionation schedules

Oncologist

Volumn 4, Issue 1, 1999, Pages 11-16

  Saunders, M I ^a  

^a MOUNT VERNON HOSPITAL   (United Kingdom)

Author keywords

Acceleration; Altered fractionation; Head and neck cancer; Hyperfractionation; Radiotherapy

Indexed keywords

CANCER CONTROL; CANCER RADIOTHERAPY; HEAD AND NECK CANCER; HUMAN; MORBIDITY; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; REVIEW;

EID: 0032998666     PISSN: 10837159     EISSN: None     Source Type: Journal    
DOI: 10.1634/theoncologist.4-1-11     Document Type: Review

References (28)

1. Thames HD, Withers HR, Peters LJ et al. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1992;8:219-226.
2. Horiot J, Le Fur R, N'Guyen T et al. Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: final analysis of a randomized trail of the EORTC cooperative group of radiotherapy. Radiother Oncol 1992;25:231-241.
3. Horiot JC, Bontempts P, Begg AG et al. New radiotherapy fractionation schemes in head and neck cancers. The EORTC trials: a benchmark. In: Kogelnik HD, Sedlymayer E, eds. Proceedings of the 6th International Meeting on Progress in Radio-Oncology VI. Bologna: Monduzzi Editore, 1998:735-741.
4. Cox J, Pajak T, Marcial V et al. Dose-response for local control with hyperfractionated radiation therapy in advanced carcinomas of the upper aerodigestive tracts: preliminary report of Radiation Therapy Oncology Group protocol 83-13. Int J Radiat Oncol Biol Phys 1990;18:515-521.
5. Wilson GD, McNally NJ, Dische S et al. Measurement of cell kinetics in human tumours in vivo using bromodeoxyuridine incorporation and flow cytometry. Br J Cancer 1988;58:423-431.
6. Bennett MH, Wilson GD, Dische S et al. Tumour proliferation assessed by combined histological and flow cytometric analysis: implications for therapy in squamous cell carcinoma in the head and neck. Br J Cancer 1992;65:870-878.
7. Maciejewski B, Preuss-Bayer G, Trott KR. The influence of the number of fractions and overall treatment time on local control and late complication rate in squamous cell carcinoma of the larynx. Int J Radiat Oncol Biol Phys 1983;9:321-328.
8. Withers HR, Taylor JMG, Maciejewski B. The hazard of accelerated tumour clonogen repopulation during radiotherapy. Acta Oncol 1988;27:131-146.
9. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-467.
10. Peracchia G, Salti C. Radiotherapy with thrice-a-day fractionation in a short overall time: clinical experiences. Int J Radiat Oncol Biol Phys 1981;7:99-104.
11. Olmi P, Cellai E, Chiavacci A et al. Accelerated fractionation in advanced head and neck cancer: results and analysis of late sequelae. Radiother Oncol 1990;17:199-207.
12. Lamb DS, Spry NA, Gray AJ et al. Accelerated fractionation radiotherapy for advanced head and neck cancer. Radiother Oncol 1990;18:107-116.
13. Overgaard J, Sand Hansden H, Sapru W et al. Conventional radiotherapy as the primary treatment of squamous cell carcinoma of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week - preliminary report from the DAHANCA 6 and 7 trial. Radiother Oncol 1996;40:S31.
14. Maciejewski B, Skladowski K, Pilecki B et al. Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity. Radiother Oncol 1996;40:137-140.
15. Maciejewski B, Skladowski K, Tarnawski R et al. Is the 7-day accelerated treatment better than conventional 5-day irradiation of head and neck cancers? In: Kogelnik HD, Sedlmayer E, eds. Proceedings of the 6th International Meeting on Progress in Radio-Oncology. Bologna: Monduzzi Editore, 1998:767-773.
16. van der Schueren E, van Den Bogaert W, Vanuytsel L et al. Radiotherapy by multiple fractions per day (MFD) in head and neck cancer: acute reactions of skin and mucosa. Int J Radiat Oncol Biol Phys 1990;19:301-311.
17. van den Bogaert W, van der Schueren E, Horiot JC et al. The EORTC randomized trial on three fractions per day and misonidazole (trial no: 22811) in advanced head and neck cancer: long-term results and side effects. Radiother Oncol 1995;35:91-99.
18. Wang CC, Suit HD, Blitzer PH. Twice-a-day radiation therapy for supraglottic carcinoma. Int J Radiat Oncol Biol Phys 1985;12:3-7.
19. Wang CC. Local control of oropharyngeal carcinoma after two accelerated hyperfractionated radiation therapy schemes. Int J Radiat Oncol Biol Phys 1988;14:1143-1146.
20. Horiot JC, Bontemps P, van den Bogaert W et al. Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial. Radiother Oncol 1997;44:111-121.
21. Knee R, Fields RS, Peters LJ. Concomitant boost radiotherapy for advanced squamous cell carcinoma of the head and neck. Radiother Oncol 1985;4:1-7.
22. Ang KK, Peters LJ, Weber RS et al. Concomitant boost radiotherapy schedules in the treatment of carcinoma of the oropharynx and nasopharynx. Int J Radiat Oncol Biol Phys 1990;19:1339-1345.
23. Saunders MI, Dische S, Hong A et al. Continuous hyperfractionated, accelerated radiotherapy in locally advanced carcinoma of the head and neck region. Int J Radiat Oncol Biol Phys 1988;17:1287-1293.
24. Dische S, Saunders M, Barrett A et al. A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer. Radiother Oncol 1997;44:123-136.
25. Thames HD. An "incomplete repair" model for survival after fractionated and continuous radiations. Int J Radiat Biol 1985;43:319-339.
26. Ang KK, Jiang GL, Guttenberger R et al. Impact of spinal cord repair kinetics on the practice of altered fractionation schedules. Radiother Oncol 1992;25:287-294.
27. Landuyt W, Fowler J, Ruifrok A et al. Kinetics of repair in the spinal cord of the rat. Radiother Oncol 1997;45:55-62.
28. N'Guyen TD, Deurange L, Froissart D et al. Rapid hyperfractionated radiotherapy. Clinical results in 178 advanced squamous cell carcinomas of the head and neck. Cancer 1985;56:16-19.